EUVIMEDEUVIMED entdecken
Klinische StudieOpen Access · CC BY 4.0

A Pilot Study of Linezolid for Early Syphilis Treatment

Ryan M Nguyen, Chrysovalantis Stafylis iD, Kelika A Konda, E Michael Reyes-Diaz iD, Kori Keith, Keith Stokes, Catherine Creticos, Candice J McNeil iD, Philip A Chan iD, James B Brock, Byron Buck, Ebony Warren und 5 weitere

Open Forum Infectious Diseases · 31.10.2026 · 13 (11)

DOI: 10.1093/ofid/ofag690 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Open Forum Infectious Diseases, online erschienen am 24.10.2026. Verfasst von Ryan M Nguyen und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, California, USA. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Coefficient Giving, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In a study of oral linezolid among 18 patients with early syphilis, 15 showed adequate serological response by 6 months. Among 6 patients treated with benzathine penicillin G, 5 showed adequate serological response. There were no serious adverse events. Linezolid shows promise for the treatment of early syphilis.

Schlagwörter

Stichwörter der Autor:innen

linezolidrepurposingsyphilistreatment

Autor:innen und Institutionen

  • Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
  • Center for Interdisciplinary Studies in Sexuality, AIDS and Society, Universidad Peruana Cayetano Heredia, Lima, Peru.
  • Open Arms Healthcare Center, Jackson, Mississippi, USA.
  • Howard Brown Health, Chicago, Illinois, USA.
  • Department of Medicine, Section of Infectious Diseases, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
  • Open Door Health, Rhode Island Public Health Institute, Providence, Rhode Island, USA.

ORCID-Profile: Chrysovalantis Stafylis, E Michael Reyes-Diaz, Candice J McNeil, Philip A Chan, Rica M Abbott

Förderung

  • NIAID NIH HHS
  • Coefficient Giving
  • National Institute of Allergy and Infectious Diseases
  • National Institutes of Health

Zitieren

APA

Nguyen, R. M., Stafylis, C., Konda, K. A., Reyes-Diaz, E. M., Keith, K., Stokes, K., Creticos, C., McNeil, C. J., Chan, P. A., Brock, J. B., Buck, B., Warren, E., Abbott, R. M., Nall, J. L., Salhaney, P., Keys, T., & Klausner, J. D. (2026). A Pilot Study of Linezolid for Early Syphilis Treatment. Open Forum Infectious Diseases, 13(11). https://doi.org/10.1093/ofid/ofag690

Vancouver

Nguyen RM, Stafylis C, Konda KA, Reyes-Diaz EM, Keith K, Stokes K, et al. A Pilot Study of Linezolid for Early Syphilis Treatment. Open Forum Infectious Diseases. 2026;13(11). doi:10.1093/ofid/ofag690

BibTeX
@article{Nguyen2026,
  author = {Nguyen, Ryan M and Stafylis, Chrysovalantis and Konda, Kelika A and Reyes-Diaz, E Michael and Keith, Kori and Stokes, Keith and Creticos, Catherine and McNeil, Candice J and Chan, Philip A and Brock, James B and Buck, Byron and Warren, Ebony and Abbott, Rica M and Nall, Jennifer L and Salhaney, Peter and Keys, Takila and Klausner, Jeffrey D},
  title = {A Pilot Study of Linezolid for Early Syphilis Treatment},
  journal = {Open Forum Infectious Diseases},
  year = {2026},
  volume = {13},
  number = {11},
  doi = {10.1093/ofid/ofag690}
}
Kostenlos starten →